Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-14 5:46 pm Purchase | 13G | ASTRIA THERAPEUTICS INC ATXS | RA CAPITAL MANAGEMENT L.P. | 5,105,213 9.000% | 692,063 (+15.68%) | View |
2024-11-14 5:45 pm Purchase | 13G | ASTRIA THERAPEUTICS INC ATXS | Venrock Healthcare Capital Partners III L.P. | 3,458,645 6.100% | 232,839 (+7.22%) | View |
2024-11-14 4:41 pm Unchanged | 13D | ASTRIA THERAPEUTICS INC ATXS | PERCEPTIVE ADVISORS LLC | 6,485,420 11.500% | 0 (Unchanged) | View |
2024-11-14 4:15 pm Purchase | 13G | ASTRIA THERAPEUTICS INC ATXS | Fairmount Funds Management LLC | 5,868,045 9.900% | 2,234,080 (+61.48%) | View |
2024-11-14 12:03 pm Purchase | 13G | ASTRIA THERAPEUTICS INC ATXS | Vestal Point Capital LP | 4,000,000 7.100% | 4,000,000 (New Position) | View |
2024-11-13 4:21 pm Sale | 13G | ASTRIA THERAPEUTICS INC ATXS | TCG Crossover GP II LLC | 2,761,861 4.900% | -1,607,067 (-36.78%) | View |
2024-11-12 1:29 pm Unchanged | 13G | ASTRIA THERAPEUTICS INC ATXS | VANGUARD GROUP INC | 2,635,520 4.670% | 0 (Unchanged) | View |
2024-11-12 09:50 am Purchase | 13G | ASTRIA THERAPEUTICS INC ATXS | FMR LLC | 8,463,678 14.999% | 1,767,714 (+26.40%) | View |
2024-11-08 2:17 pm Unchanged | 13G | ASTRIA THERAPEUTICS INC ATXS | BlackRock Inc. BLK | 3,499,478 6.200% | 0 (Unchanged) | View |
2024-11-04 12:37 pm Unchanged | 13G | ASTRIA THERAPEUTICS INC ATXS | VANGUARD GROUP INC | 2,635,520 4.670% | 0 (Unchanged) | View |
2024-11-04 11:39 am Unchanged | 13G | ASTRIA THERAPEUTICS INC ATXS | VANGUARD GROUP INC | 2,635,520 4.670% | 0 (Unchanged) | View |
2024-11-04 11:39 am Purchase | 13G | ASTRIA THERAPEUTICS INC ATXS | VANGUARD GROUP INC | 2,635,520 4.670% | 579,813 (+28.21%) | View |
2024-11-01 4:05 pm Purchase | 13G | ASTRIA THERAPEUTICS INC ATXS | INTEGRATED CORE STRATEGIES (US) LLC | 2,948,876 5.200% | 2,948,876 (New Position) | View |
2024-10-24 2:02 pm Purchase | 13G | ASTRIA THERAPEUTICS INC ATXS | BlackRock Inc. BLK | 3,499,478 6.200% | 1,043,825 (+42.51%) | View |
2024-07-10 10:10 am Purchase | 13G | ASTRIA THERAPEUTICS INC ATXS | FMR LLC | 6,695,964 12.193% | 1,732,228 (+34.90%) | View |
2024-03-11 08:19 am Sale | 13G | ASTRIA THERAPEUTICS INC ATXS | FMR LLC | 4,963,736 9.080% | -480,692 (-8.83%) | View |
2024-03-07 12:29 pm Purchase | 13G | ASTRIA THERAPEUTICS INC ATXS | BlackRock Inc. BLK | 2,455,653 4.500% | 271,095 (+12.41%) | View |
2024-02-14 3:48 pm Purchase | 13G | ASTRIA THERAPEUTICS INC ATXS | Fairmount Funds Management LLC | 3,633,965 9.900% | 1,732,568 (+91.12%) | View |
2024-02-14 3:00 pm Sale | 13G | ASTRIA THERAPEUTICS INC ATXS | Cormorant Asset Management LP | 0 0.000% | -1,650,000 (Position Closed) | View |
2024-02-14 08:36 am Sale | 13G | ASTRIA THERAPEUTICS INC ATXS | Deep Track Capital LP | 0 0.000% | -1,816,531 (Position Closed) | View |